Entheon Biomedical (XCNQ:ENBI) Pre-Tax Income : C$-0.28 Mil (TTM As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Entheon Biomedical's pretax income for the three months ended in Feb. 2024 was C$-0.08 Mil. Its pretax income for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.28 Mil. Entheon Biomedical's pretax margin was %.

During the past 7 years, Entheon Biomedical's highest Pretax Margin was -120.00%. The lowest was -1084.74%. And the median was -602.37%.

Entheon Biomedical Pre-Tax Income Historical Data

The historical data trend for Entheon Biomedical's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Pre-Tax Income Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Pre-Tax Income

Get a 7-Day Free Trial

-0.23

-0.15

-8.00

-2.06

-0.30

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Pre-Tax Income	Get a 7-Day Free Trial															-0.10	-0.04	-0.10	-0.07	-0.08

Competitive Comparison of Entheon Biomedical's Pre-Tax Income

For the Biotechnology subindustry, Entheon Biomedical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Pre-Tax Income falls into.

Entheon Biomedical Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Entheon Biomedical's Pretax Income for the fiscal year that ended in Nov. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.314	+	0.005	+	0	+	0.007	+	0.002
	=	-0.30

Entheon Biomedical's Pretax Income for the quarter that ended in Feb. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.078	+	0	+	0	+	0.003	+	0
	=	-0.08

Pre-Tax Income for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.28 Mil.

Entheon Biomedical (XCNQ:ENBI) Pre-Tax Income Explanation

Entheon Biomedical's Pretax Margin for the quarter that ended in Feb. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.075	/	0
	=	%

During the past 7 years, Entheon Biomedical's highest Pretax Margin was -120.00%. The lowest was -1084.74%. And the median was -602.37%.

Entheon Biomedical Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines